Merck says pill cuts risk of Covid-19 hospitalization, death in half as many states see vaccinations increase
Merck says pill cuts risk of Covid-19 hospitalization, death in half as many states see vaccinations increase
By Travis Caldwell | CNN
A pill has cut the risk of hospitalization or death from Covid-19 by half in a study, Merck and Ridgeback Therapeutic said Friday.
It would become the first oral antiviral for Covid-19 if approved by the US Food and Drug Administration for emergency use authorization.
“At the interim analysis, molnupiravir reduced the risk of hospitalization or death by approximately…
Discover more from USNewsRank
Subscribe to get the latest posts sent to your email.